The mediating effect of sleep duration on metabolic syndrome severity in adults: a structural equation modeling approach
BMC Endocrine Disorders · 2024
DOI: 10.1186/s12902-024-01611-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Niloufar Hemati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Metabolic Syndrome, Sleep, Severity of Illness Index. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is associated to sleep duration. It is crucial to identify factors that disrupt sleep regulation. The study aimed to assess the indirect effect of risk factors related to MetS severity through sleep duration by utilizing a structural equation model (SEM).
Methods
The study involving 3,935 adults from the baseline data of the Ravansar Non-Communicable Disease (RaNCD) cohort study. MetS severity scores were the outcome variables. SEM was employed to explore the relationships, utilizing IBM SPSS and AMOS version 23.
Results
The mean MetS severity score was higher in women compared to men (0.25 vs. 0.16, P = 0.003). In men, socioeconomic status (SES) has a positive direct effect (β = 0.048) and a negative indirect effect (β=-0.006) on MetS severity. Increased physical activity is directly (β=-0.036) and indirectly (β=-0.093) associated with reducing MetS severity. Nap duration is directly linked to an increase (β = 0.072) but has an indirect effect (β=-0.008) in decreasing MetS severity. In women, SES has a direct (β=-0.020) and indirect (β=-0.001) inverse relationship with MetS severity. Increased physical activity is directly (β=-0.048) and indirectly (β=-0.036) associated with decreasing MetS severity in women. Nap duration is directly associated with an increase in MetS severity (β=-0.018) but indirectly contributes to its reduction (β=-0.002). Sleep duration not only directly affects MetS severity but is also influenced by age, SES, physical activity, obesity and nap duration.
Conclusion
Physical activity, SES, and nap duration directly and indirectly effect the MetS severity. Sleep duration was recognized as a mediating variable that supports the indirect effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Department, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Sleep Disorders Research Center, Kermanshah University of Medical sciences, Kermanshah, Iran.
- Social Development and Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. m.darbandi@kums.ac.ir.
Zitieren
APA
Hemati, N., Satari, S., Khazaie, H., Salimi, Y., Najafi, F., Pasdar, Y., & Darbandi, M. (2024). The mediating effect of sleep duration on metabolic syndrome severity in adults: a structural equation modeling approach. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01611-7
Vancouver
Hemati N, Satari S, Khazaie H, Salimi Y, Najafi F, Pasdar Y, et al. The mediating effect of sleep duration on metabolic syndrome severity in adults: a structural equation modeling approach. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01611-7
BibTeX
@article{Hemati2024,
author = {Hemati, Niloufar and Satari, Shabnam and Khazaie, Habibolah and Salimi, Yahya and Najafi, Farid and Pasdar, Yahya and Darbandi, Mitra},
title = {The mediating effect of sleep duration on metabolic syndrome severity in adults: a structural equation modeling approach},
journal = {BMC Endocrine Disorders},
year = {2024},
doi = {10.1186/s12902-024-01611-7}
}
EUVIMED